Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ceribell, Inc.CBLL · Entity 4994 | Director | June 02, 2026 | June 04, 2026 |
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ceribell, Inc.
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,587 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 7,838 · Balance 26,587 F1: Represents restricted stock units ("RSUs"). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs").
TANDEM DIABETES CARE INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,542 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Exercise / conversion · Acquired 8,759 · Balance 22,542 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 10,220 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Grant · Acquired 10,220 · Balance 10,220 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Exercise / conversion · Disposed 8,759 · Balance 0 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.
F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2021 Filed Jun 10, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 500 | $90.00 | $45,000.00 |
DisclosureSEC source: 0001438133-21-000098 · wf-form4_162335875512522.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,892 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 500 | $34.00 | $17,000.00 |
DisclosureSEC source: 0001438133-21-000098 · wf-form4_162335875512522.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000088 · wf-form4_162275456876148.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,000 | $85.11 | $85,114.50 |
DisclosureSEC source: 0001438133-21-000088 · wf-form4_162275456876148.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,892 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $85 to $85.52. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:10 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,000 | $34.00 | $34,000.00 |
DisclosureSEC source: 0001438133-21-000088 · wf-form4_162275456876148.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 23:17 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000078 · wf-form4_162258944780428.xml · derivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,892 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company. F3 · kind: This RSU award was granted on May 27, 2020. 100% of the RSU vested on May 27, 2021. F4 · derivative.exercise_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021. F4 · derivative.expiration_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 23:17 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000078 · wf-form4_162258944780428.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 2,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000053 · wf-form4_162156085255118.xml · derivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,205 Underlying: Common Stock · 2,205 shares Expires not disclosed F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,500 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000017 · wf-form4_161481794577214.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,500 | $96.14 | $144,213.90 |
DisclosureSEC source: 0001438133-21-000017 · wf-form4_161481794577214.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $95.72 to $96.58. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:32 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,500 | $34.00 | $51,000.00 |
DisclosureSEC source: 0001438133-21-000017 · wf-form4_161481794577214.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:49 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,500 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000163 · wf-form4_160703217645792.xml · derivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,000 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:49 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,500 | $94.03 | $141,040.20 |
DisclosureSEC source: 0001438133-20-000163 · wf-form4_160703217645792.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $93.89 to $94.31. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:49 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,500 | $34.00 | $51,000.00 |
DisclosureSEC source: 0001438133-20-000163 · wf-form4_160703217645792.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 9,500 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000138 · wf-form4_159925215958139.xml · derivative · entry 7 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,500 Underlying: Common Stock · 9,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019. F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 500 | $116.89 | $58,445.00 |
DisclosureSEC source: 0001438133-20-000138 · wf-form4_159925215958139.xml · nonDerivative · entry 6 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 866 | $115.38 | $99,920.55 |
DisclosureSEC source: 0001438133-20-000138 · wf-form4_159925215958139.xml · nonDerivative · entry 5 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020. F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $115.15 to $116.00. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 4,466 | $114.58 | $511,693.29 |
DisclosureSEC source: 0001438133-20-000138 · wf-form4_159925215958139.xml · nonDerivative · entry 4 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,366 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $114.12 to $115.11. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,800 | $113.61 | $204,502.86 |
DisclosureSEC source: 0001438133-20-000138 · wf-form4_159925215958139.xml · nonDerivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,832 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $113.10 to $114.05. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,868 | $112.31 | $209,793.96 |
DisclosureSEC source: 0001438133-20-000138 · wf-form4_159925215958139.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,632 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $112.02 to $113.00. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 9,500 | $34.00 | $323,000.00 |
DisclosureSEC source: 0001438133-20-000138 · wf-form4_159925215958139.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| May 27, 2020 Filed May 30, 2020 00:49 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 1,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000077 · wf-form4_159079975986456.xml · derivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,892 Underlying: Common Stock · 1,892 shares Expires not disclosed F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:40 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 1,555 | $0.00 Strike: $64.66 | $0.00 |
DisclosureSEC source: 0001209191-19-038305 · doc4.xml · derivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,555 Underlying: Common Stock · 1,555 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 02, 2019 Filed Jan 8, 2019 22:20 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001209191-19-002852 · doc4.xml · derivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in 36 equal monthly installments commencing one month following the date of grant. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.